SKI Market

Indian Indices

Nifty

26,215.55 10.25
(0.04%)

Sensex

85,886.38 166.00
( 0.19%)

Bank Nifty

59,737.30 209.25
( 0.35%)

Nifty IT

37,446.30 81.70
( 0.22%)

Global Indices

Nasdaq

47,448.12 314.66
(0.67%)

Dow Jones

6,833.61 46.73
(0.69%)

Hang Seng

50,154.28 595.21
(1.20%)

Nikkei 225

9,688.31 -3.27
(-0.03%)

Forex

USD-INR

89.20 0.05
(0.06%)

EUR-INR

103.32 0.40
(0.39%)

GBP-INR

117.74 0.57
(0.49%)

JPY-INR

0.57 0.00
(0.07%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Divis Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

532488

INE361B01024

578.2640535

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DIVISLAB

68.53

172287.78

EPS(TTM)

Face Value()

Div & Yield %

94.7

0.46

Back

Divi's Laboratories consolidated net profit rises 35.10% in the September 2025 quarter

Nov 07,2025

Net profit of Divi's Laboratories rose 35.10% to Rs 689.00 crore in the quarter ended September 2025 as against Rs 510.00 crore during the previous quarter ended September 2024. Sales rose 16.12% to Rs 2715.00 crore in the quarter ended September 2025 as against Rs 2338.00 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	2715.00	2338.00	16
OPM %	32.71	30.62	-
PBDT	1025.00	821.00	25
PBT	912.00	722.00	26
NP	689.00	510.00	35

26,215.55 10.25 (0.04%)

85,886.38 166.00 ( 0.19%)

59,737.30 209.25 ( 0.35%)

37,446.30 81.70 ( 0.22%)

47,448.12 314.66 (0.67%)

6,833.61 46.73 (0.69%)

50,154.28 595.21 (1.20%)

9,688.31 -3.27 (-0.03%)

89.20 0.05 (0.06%)

103.32 0.40 (0.39%)

117.74 0.57 (0.49%)

0.57 0.00 (0.07%)